These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30684554)

  • 1. Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes.
    Moos S; Mohebiany AN; Waisman A; Kurschus FC
    J Invest Dermatol; 2019 May; 139(5):1110-1117. PubMed ID: 30684554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
    Srikanth M; Rasool M
    Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
    Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
    Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
    El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
    J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice.
    Yamaguchi Y; Watanabe Y; Watanabe T; Komitsu N; Aihara M
    J Invest Dermatol; 2015 Nov; 135(11):2764-2774. PubMed ID: 26134945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
    Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
    Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
    Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
    Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
    PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncogenic kinase TOPK upregulates in psoriatic keratinocytes and contributes to psoriasis progression by regulating neutrophils infiltration.
    Zeng F; Du S; Wu M; Dai C; Li J; Wang J; Hu G; Cai P; Wang L
    Cell Commun Signal; 2024 Aug; 22(1):386. PubMed ID: 39090602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
    Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
    J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis.
    Sumida H; Yanagida K; Kita Y; Abe J; Matsushima K; Nakamura M; Ishii S; Sato S; Shimizu T
    J Immunol; 2014 May; 192(9):4361-9. PubMed ID: 24663678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice.
    Hernández-Santana YE; Leon G; St Leger D; Fallon PG; Walsh PT
    Life Sci Alliance; 2020 Apr; 3(4):. PubMed ID: 32086318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation.
    Su Y; Huang J; Zhao X; Lu H; Wang W; Yang XO; Shi Y; Wang X; Lai Y; Dong C
    Sci Immunol; 2019 Jun; 4(36):. PubMed ID: 31175175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
    Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
    Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
    J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
    Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
    Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.